Bafna Pharmaceuticals (NSE:BAFNAPH) 3-Year EBITDA Growth Rate : 138.10% (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Bafna Pharmaceuticals 3-Year EBITDA Growth Rate?

Bafna Pharmaceuticals's EBITDA per Share for the three months ended in Dec. 2023 was ₹-0.46.

During the past 12 months, Bafna Pharmaceuticals's average EBITDA Per Share Growth Rate was 65.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 138.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Bafna Pharmaceuticals was 138.10% per year. The lowest was -65.10% per year. And the median was 28.35% per year.

Competitive Comparison of Bafna Pharmaceuticals's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Bafna Pharmaceuticals's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bafna Pharmaceuticals's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bafna Pharmaceuticals's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Bafna Pharmaceuticals's 3-Year EBITDA Growth Rate falls into.

Bafna Pharmaceuticals 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Bafna Pharmaceuticals (NSE:BAFNAPH) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Bafna Pharmaceuticals 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Bafna Pharmaceuticals's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bafna Pharmaceuticals (NSE:BAFNAPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bafna Pharmaceuticals Ltd (NSE:BAFNAPH) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

532989:India

Address

Thambu Chetty Street, New No. 68, Old No.299, Bafna Towers, Chennai, TN, IND, 600001

Website

http://www.bafnapharma.com

Bafna Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in the manufacturing and marketing of drugs and medicines. The company sells its products in India and international regions. The company has only one Segment of Business namely Pharmaceuticals.

Bafna Pharmaceuticals (NSE:BAFNAPH) Headlines

No Headlines